Click for best price
Hypertension Medications Market Size, Share 2024
The global Hypertension Medications market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Calcium Channel Blockers Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Hypertension Medications include Pfizer, Novartis, AstraZeneca, Bayer, Sanofi, Boehringer Ingelheim, Merck, Lupin Pharmaceuticals and Huahai Pharmaceutical, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
High blood pressure is a common condition that affects the body's arteries. It's also called hypertension. If you have high blood pressure, the force of the blood pushing against the artery walls is consistently too high. The heart has to work harder to pump blood. There are many different high blood pressure medications (antihypertensives) available, each with pros and cons.
This report aims to provide a comprehensive presentation of the global market for Hypertension Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hypertension Medications. This report contains market size and forecasts of Hypertension Medications in global, including the following market information:
Global Hypertension Medications Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Hypertension Medications companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hypertension Medications Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Hypertension Medications Market Segment Percentages, by Type, 2023 (%)
Calcium Channel Blockers
ACE Inhibitors
Angiotensin II Receptor Blockers
Beta Blockers
Compound Drugs
Diuretics
Others
Global Hypertension Medications Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Hypertension Medications Market Segment Percentages, by Application, 2023 (%)
Hospital
Clinic
Others
Global Hypertension Medications Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Hypertension Medications Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hypertension Medications revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Hypertension Medications revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
AstraZeneca
Bayer
Sanofi
Boehringer Ingelheim
Merck
Lupin Pharmaceuticals
Huahai Pharmaceutical
Jiangsu Jibeier Pharmaceutical
Tianjin Pharmaceutical Da Ren Tang Group
Chengdu Easton Biopharmaceuticals
Qingdao Huanghai Pharmaceutical
CR Double-Crane
Shanghai Shyndec Pharmaceutical
CSPC Pharmaceutical Group
Jiangsu Hengrui Medicine
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hypertension Medications, market overview.
Chapter 2: Global Hypertension Medications market size in revenue.
Chapter 3: Detailed analysis of Hypertension Medications company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hypertension Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Hypertension Medications Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
108 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hypertension Medications Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hypertension Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hypertension Medications Overall Market Size
2.1 Global Hypertension Medications Market Size: 2023 VS 2030
2.2 Global Hypertension Medications Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hypertension Medications Players in Global Market
3.2 Top Global Hypertension Medications Companies Ranked by Revenue
3.3 Global Hypertension Medications Revenue by Companies
3.4 Top 3 and Top 5 Hypertension Medications Companies in Global Market, by Revenue in 2023
3.5 Global Companies Hypertension Medications Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hypertension Medications Players in Global Market
3.6.1 List of Global Tier 1 Hypertension Medications Companies
3.6.2 List of Global Tier 2 and Tier 3 Hypertension Medications Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hypertension Medications Market Size Markets, 2023 & 2030
4.1.2 Calcium Channel Blockers
4.1.3 ACE Inhibitors
4.1.4 Angiotensin II Receptor Blockers
4.1.5 Beta Blockers
4.1.6 Compound Drugs
4.1.7 Diuretics
4.1.8 Others
4.2 By Type - Global Hypertension Medications Revenue & Forecasts
4.2.1 By Type - Global Hypertension Medications Revenue, 2019-2024
4.2.2 By Type - Global Hypertension Medications Revenue, 2025-2030
4.2.3 By Type - Global Hypertension Medications Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hypertension Medications Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Hypertension Medications Revenue & Forecasts
5.2.1 By Application - Global Hypertension Medications Revenue, 2019-2024
5.2.2 By Application - Global Hypertension Medications Revenue, 2025-2030
5.2.3 By Application - Global Hypertension Medications Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Hypertension Medications Market Size, 2023 & 2030
6.2 By Region - Global Hypertension Medications Revenue & Forecasts
6.2.1 By Region - Global Hypertension Medications Revenue, 2019-2024
6.2.2 By Region - Global Hypertension Medications Revenue, 2025-2030
6.2.3 By Region - Global Hypertension Medications Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Hypertension Medications Revenue, 2019-2030
6.3.2 US Hypertension Medications Market Size, 2019-2030
6.3.3 Canada Hypertension Medications Market Size, 2019-2030
6.3.4 Mexico Hypertension Medications Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Hypertension Medications Revenue, 2019-2030
6.4.2 Germany Hypertension Medications Market Size, 2019-2030
6.4.3 France Hypertension Medications Market Size, 2019-2030
6.4.4 U.K. Hypertension Medications Market Size, 2019-2030
6.4.5 Italy Hypertension Medications Market Size, 2019-2030
6.4.6 Russia Hypertension Medications Market Size, 2019-2030
6.4.7 Nordic Countries Hypertension Medications Market Size, 2019-2030
6.4.8 Benelux Hypertension Medications Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Hypertension Medications Revenue, 2019-2030
6.5.2 China Hypertension Medications Market Size, 2019-2030
6.5.3 Japan Hypertension Medications Market Size, 2019-2030
6.5.4 South Korea Hypertension Medications Market Size, 2019-2030
6.5.5 Southeast Asia Hypertension Medications Market Size, 2019-2030
6.5.6 India Hypertension Medications Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Hypertension Medications Revenue, 2019-2030
6.6.2 Brazil Hypertension Medications Market Size, 2019-2030
6.6.3 Argentina Hypertension Medications Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hypertension Medications Revenue, 2019-2030
6.7.2 Turkey Hypertension Medications Market Size, 2019-2030
6.7.3 Israel Hypertension Medications Market Size, 2019-2030
6.7.4 Saudi Arabia Hypertension Medications Market Size, 2019-2030
6.7.5 UAE Hypertension Medications Market Size, 2019-2030
7 Hypertension Medications Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Hypertension Medications Major Product Offerings
7.1.4 Pfizer Hypertension Medications Revenue in Global Market (2019-2024)
7.1.5 Pfizer Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Hypertension Medications Major Product Offerings
7.2.4 Novartis Hypertension Medications Revenue in Global Market (2019-2024)
7.2.5 Novartis Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Hypertension Medications Major Product Offerings
7.3.4 AstraZeneca Hypertension Medications Revenue in Global Market (2019-2024)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Hypertension Medications Major Product Offerings
7.4.4 Bayer Hypertension Medications Revenue in Global Market (2019-2024)
7.4.5 Bayer Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Hypertension Medications Major Product Offerings
7.5.4 Sanofi Hypertension Medications Revenue in Global Market (2019-2024)
7.5.5 Sanofi Key News & Latest Developments
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Hypertension Medications Major Product Offerings
7.6.4 Boehringer Ingelheim Hypertension Medications Revenue in Global Market (2019-2024)
7.6.5 Boehringer Ingelheim Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Hypertension Medications Major Product Offerings
7.7.4 Merck Hypertension Medications Revenue in Global Market (2019-2024)
7.7.5 Merck Key News & Latest Developments
7.8 Lupin Pharmaceuticals
7.8.1 Lupin Pharmaceuticals Company Summary
7.8.2 Lupin Pharmaceuticals Business Overview
7.8.3 Lupin Pharmaceuticals Hypertension Medications Major Product Offerings
7.8.4 Lupin Pharmaceuticals Hypertension Medications Revenue in Global Market (2019-2024)
7.8.5 Lupin Pharmaceuticals Key News & Latest Developments
7.9 Huahai Pharmaceutical
7.9.1 Huahai Pharmaceutical Company Summary
7.9.2 Huahai Pharmaceutical Business Overview
7.9.3 Huahai Pharmaceutical Hypertension Medications Major Product Offerings
7.9.4 Huahai Pharmaceutical Hypertension Medications Revenue in Global Market (2019-2024)
7.9.5 Huahai Pharmaceutical Key News & Latest Developments
7.10 Jiangsu Jibeier Pharmaceutical
7.10.1 Jiangsu Jibeier Pharmaceutical Company Summary
7.10.2 Jiangsu Jibeier Pharmaceutical Business Overview
7.10.3 Jiangsu Jibeier Pharmaceutical Hypertension Medications Major Product Offerings
7.10.4 Jiangsu Jibeier Pharmaceutical Hypertension Medications Revenue in Global Market (2019-2024)
7.10.5 Jiangsu Jibeier Pharmaceutical Key News & Latest Developments
7.11 Tianjin Pharmaceutical Da Ren Tang Group
7.11.1 Tianjin Pharmaceutical Da Ren Tang Group Company Summary
7.11.2 Tianjin Pharmaceutical Da Ren Tang Group Business Overview
7.11.3 Tianjin Pharmaceutical Da Ren Tang Group Hypertension Medications Major Product Offerings
7.11.4 Tianjin Pharmaceutical Da Ren Tang Group Hypertension Medications Revenue in Global Market (2019-2024)
7.11.5 Tianjin Pharmaceutical Da Ren Tang Group Key News & Latest Developments
7.12 Chengdu Easton Biopharmaceuticals
7.12.1 Chengdu Easton Biopharmaceuticals Company Summary
7.12.2 Chengdu Easton Biopharmaceuticals Business Overview
7.12.3 Chengdu Easton Biopharmaceuticals Hypertension Medications Major Product Offerings
7.12.4 Chengdu Easton Biopharmaceuticals Hypertension Medications Revenue in Global Market (2019-2024)
7.12.5 Chengdu Easton Biopharmaceuticals Key News & Latest Developments
7.13 Qingdao Huanghai Pharmaceutical
7.13.1 Qingdao Huanghai Pharmaceutical Company Summary
7.13.2 Qingdao Huanghai Pharmaceutical Business Overview
7.13.3 Qingdao Huanghai Pharmaceutical Hypertension Medications Major Product Offerings
7.13.4 Qingdao Huanghai Pharmaceutical Hypertension Medications Revenue in Global Market (2019-2024)
7.13.5 Qingdao Huanghai Pharmaceutical Key News & Latest Developments
7.14 CR Double-Crane
7.14.1 CR Double-Crane Company Summary
7.14.2 CR Double-Crane Business Overview
7.14.3 CR Double-Crane Hypertension Medications Major Product Offerings
7.14.4 CR Double-Crane Hypertension Medications Revenue in Global Market (2019-2024)
7.14.5 CR Double-Crane Key News & Latest Developments
7.15 Shanghai Shyndec Pharmaceutical
7.15.1 Shanghai Shyndec Pharmaceutical Company Summary
7.15.2 Shanghai Shyndec Pharmaceutical Business Overview
7.15.3 Shanghai Shyndec Pharmaceutical Hypertension Medications Major Product Offerings
7.15.4 Shanghai Shyndec Pharmaceutical Hypertension Medications Revenue in Global Market (2019-2024)
7.15.5 Shanghai Shyndec Pharmaceutical Key News & Latest Developments
7.16 CSPC Pharmaceutical Group
7.16.1 CSPC Pharmaceutical Group Company Summary
7.16.2 CSPC Pharmaceutical Group Business Overview
7.16.3 CSPC Pharmaceutical Group Hypertension Medications Major Product Offerings
7.16.4 CSPC Pharmaceutical Group Hypertension Medications Revenue in Global Market (2019-2024)
7.16.5 CSPC Pharmaceutical Group Key News & Latest Developments
7.17 Jiangsu Hengrui Medicine
7.17.1 Jiangsu Hengrui Medicine Company Summary
7.17.2 Jiangsu Hengrui Medicine Business Overview
7.17.3 Jiangsu Hengrui Medicine Hypertension Medications Major Product Offerings
7.17.4 Jiangsu Hengrui Medicine Hypertension Medications Revenue in Global Market (2019-2024)
7.17.5 Jiangsu Hengrui Medicine Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hypertension Medications Market Opportunities & Trends in Global Market
Table 2. Hypertension Medications Market Drivers in Global Market
Table 3. Hypertension Medications Market Restraints in Global Market
Table 4. Key Players of Hypertension Medications in Global Market
Table 5. Top Hypertension Medications Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Hypertension Medications Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Hypertension Medications Revenue Share by Companies, 2019-2024
Table 8. Global Companies Hypertension Medications Product Type
Table 9. List of Global Tier 1 Hypertension Medications Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hypertension Medications Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Hypertension Medications Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Hypertension Medications Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Hypertension Medications Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Hypertension Medications Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Hypertension Medications Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Hypertension Medications Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Hypertension Medications Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Hypertension Medications Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Hypertension Medications Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Hypertension Medications Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Hypertension Medications Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Hypertension Medications Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Hypertension Medications Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Hypertension Medications Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Hypertension Medications Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Hypertension Medications Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Hypertension Medications Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Hypertension Medications Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Hypertension Medications Revenue, (US$, Mn), 2025-2030
Table 30. Pfizer Company Summary
Table 31. Pfizer Hypertension Medications Product Offerings
Table 32. Pfizer Hypertension Medications Revenue (US$, Mn) & (2019-2024)
Table 33. Pfizer Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Hypertension Medications Product Offerings
Table 36. Novartis Hypertension Medications Revenue (US$, Mn) & (2019-2024)
Table 37. Novartis Key News & Latest Developments
Table 38. AstraZeneca Company Summary
Table 39. AstraZeneca Hypertension Medications Product Offerings
Table 40. AstraZeneca Hypertension Medications Revenue (US$, Mn) & (2019-2024)
Table 41. AstraZeneca Key News & Latest Developments
Table 42. Bayer Company Summary
Table 43. Bayer Hypertension Medications Product Offerings
Table 44. Bayer Hypertension Medications Revenue (US$, Mn) & (2019-2024)
Table 45. Bayer Key News & Latest Developments
Table 46. Sanofi Company Summary
Table 47. Sanofi Hypertension Medications Product Offerings
Table 48. Sanofi Hypertension Medications Revenue (US$, Mn) & (2019-2024)
Table 49. Sanofi Key News & Latest Developments
Table 50. Boehringer Ingelheim Company Summary
Table 51. Boehringer Ingelheim Hypertension Medications Product Offerings
Table 52. Boehringer Ingelheim Hypertension Medications Revenue (US$, Mn) & (2019-2024)
Table 53. Boehringer Ingelheim Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Hypertension Medications Product Offerings
Table 56. Merck Hypertension Medications Revenue (US$, Mn) & (2019-2024)
Table 57. Merck Key News & Latest Developments
Table 58. Lupin Pharmaceuticals Company Summary
Table 59. Lupin Pharmaceuticals Hypertension Medications Product Offerings
Table 60. Lupin Pharmaceuticals Hypertension Medications Revenue (US$, Mn) & (2019-2024)
Table 61. Lupin Pharmaceuticals Key News & Latest Developments
Table 62. Huahai Pharmaceutical Company Summary
Table 63. Huahai Pharmaceutical Hypertension Medications Product Offerings
Table 64. Huahai Pharmaceutical Hypertension Medications Revenue (US$, Mn) & (2019-2024)
Table 65. Huahai Pharmaceutical Key News & Latest Developments
Table 66. Jiangsu Jibeier Pharmaceutical Company Summary
Table 67. Jiangsu Jibeier Pharmaceutical Hypertension Medications Product Offerings
Table 68. Jiangsu Jibeier Pharmaceutical Hypertension Medications Revenue (US$, Mn) & (2019-2024)
Table 69. Jiangsu Jibeier Pharmaceutical Key News & Latest Developments
Table 70. Tianjin Pharmaceutical Da Ren Tang Group Company Summary
Table 71. Tianjin Pharmaceutical Da Ren Tang Group Hypertension Medications Product Offerings
Table 72. Tianjin Pharmaceutical Da Ren Tang Group Hypertension Medications Revenue (US$, Mn) & (2019-2024)
Table 73. Tianjin Pharmaceutical Da Ren Tang Group Key News & Latest Developments
Table 74. Chengdu Easton Biopharmaceuticals Company Summary
Table 75. Chengdu Easton Biopharmaceuticals Hypertension Medications Product Offerings
Table 76. Chengdu Easton Biopharmaceuticals Hypertension Medications Revenue (US$, Mn) & (2019-2024)
Table 77. Chengdu Easton Biopharmaceuticals Key News & Latest Developments
Table 78. Qingdao Huanghai Pharmaceutical Company Summary
Table 79. Qingdao Huanghai Pharmaceutical Hypertension Medications Product Offerings
Table 80. Qingdao Huanghai Pharmaceutical Hypertension Medications Revenue (US$, Mn) & (2019-2024)
Table 81. Qingdao Huanghai Pharmaceutical Key News & Latest Developments
Table 82. CR Double-Crane Company Summary
Table 83. CR Double-Crane Hypertension Medications Product Offerings
Table 84. CR Double-Crane Hypertension Medications Revenue (US$, Mn) & (2019-2024)
Table 85. CR Double-Crane Key News & Latest Developments
Table 86. Shanghai Shyndec Pharmaceutical Company Summary
Table 87. Shanghai Shyndec Pharmaceutical Hypertension Medications Product Offerings
Table 88. Shanghai Shyndec Pharmaceutical Hypertension Medications Revenue (US$, Mn) & (2019-2024)
Table 89. Shanghai Shyndec Pharmaceutical Key News & Latest Developments
Table 90. CSPC Pharmaceutical Group Company Summary
Table 91. CSPC Pharmaceutical Group Hypertension Medications Product Offerings
Table 92. CSPC Pharmaceutical Group Hypertension Medications Revenue (US$, Mn) & (2019-2024)
Table 93. CSPC Pharmaceutical Group Key News & Latest Developments
Table 94. Jiangsu Hengrui Medicine Company Summary
Table 95. Jiangsu Hengrui Medicine Hypertension Medications Product Offerings
Table 96. Jiangsu Hengrui Medicine Hypertension Medications Revenue (US$, Mn) & (2019-2024)
Table 97. Jiangsu Hengrui Medicine Key News & Latest Developments
List of Figures
Figure 1. Hypertension Medications Segment by Type in 2023
Figure 2. Hypertension Medications Segment by Application in 2023
Figure 3. Global Hypertension Medications Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Hypertension Medications Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Hypertension Medications Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hypertension Medications Revenue in 2023
Figure 8. By Type - Global Hypertension Medications Revenue Market Share, 2019-2030
Figure 9. By Application - Global Hypertension Medications Revenue Market Share, 2019-2030
Figure 10. By Type - Global Hypertension Medications Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Hypertension Medications Revenue Market Share, 2019-2030
Figure 12. By Application - Global Hypertension Medications Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Hypertension Medications Revenue Market Share, 2019-2030
Figure 14. By Region - Global Hypertension Medications Revenue Market Share, 2019-2030
Figure 15. By Country - North America Hypertension Medications Revenue Market Share, 2019-2030
Figure 16. US Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Hypertension Medications Revenue Market Share, 2019-2030
Figure 20. Germany Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 21. France Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Hypertension Medications Revenue Market Share, 2019-2030
Figure 28. China Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 32. India Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Hypertension Medications Revenue Market Share, 2019-2030
Figure 34. Brazil Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Hypertension Medications Revenue Market Share, 2019-2030
Figure 37. Turkey Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Hypertension Medications Revenue, (US$, Mn), 2019-2030
Figure 41. Pfizer Hypertension Medications Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Novartis Hypertension Medications Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. AstraZeneca Hypertension Medications Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Bayer Hypertension Medications Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Sanofi Hypertension Medications Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Boehringer Ingelheim Hypertension Medications Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Merck Hypertension Medications Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Lupin Pharmaceuticals Hypertension Medications Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Huahai Pharmaceutical Hypertension Medications Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Jiangsu Jibeier Pharmaceutical Hypertension Medications Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Tianjin Pharmaceutical Da Ren Tang Group Hypertension Medications Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Chengdu Easton Biopharmaceuticals Hypertension Medications Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Qingdao Huanghai Pharmaceutical Hypertension Medications Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. CR Double-Crane Hypertension Medications Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Shanghai Shyndec Pharmaceutical Hypertension Medications Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. CSPC Pharmaceutical Group Hypertension Medications Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 57. Jiangsu Hengrui Medicine Hypertension Medications Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
